Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Kazuki MaesakaRyotaro SakamoriRyoko YamadaAkira DoiYuki TahataKazuyoshi OhkawaMasahide OshitaMasanori MiyazakiTakayuki YakushijinYasutoshi NozakiKengo MatsumotoSatoshi TanakaAkira KanekoSadaharu IioTakatoshi NawaYukinori YamadaNaoki MorishitaTakeo UsuiNaoki HiramatsuYoshinori DoiMitsuru SakakibaraKazuho ImanakaYuichi YoshidaTakahiro KodamaHayato HikitaTomohide TatsumiTetsuo TakeharaPublished in: PloS one (2023)
Prior ATB use was associated with reduced therapeutic responses in patients with HCC receiving atezolizumab plus bevacizumab.
Keyphrases